XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net sales $ 2,169,380 $ 1,780,215 $ 1,259,313
Cost of sales 1,808,670 1,542,673 1,130,194
Asset Impairment Cost 0 0 14,800
Gross profit 360,710 237,542 114,319
Selling, general and administrative expenses 132,792 131,772 130,942
Research and development expenses 10,404 10,104 9,013
Royalty expense 11,712 10,491 9,715
Income (loss) from operations 205,802 85,175 (35,351)
Interest expense (29,796) (32,221) (30,554)
Loss on senior note repurchase 0 (16,020) 0
Foreign exchange gain (loss) 927 12,020 (11,025)
Other income 25,420 2,086 18,799
Income (loss) before income taxes 202,353 51,040 (58,131)
Provision for income taxes 23,167 1,149 6,946
Net income (loss) 179,186 49,891 (65,077)
Net income (loss) attributable to noncontrolling interests (2,884) (305) 4,689
Net income (loss) applicable to common shareholders $ 176,302 $ 49,586 $ (60,388)
Earnings (loss) per common share:      
Basic $ 2.80 $ 0.80 $ (0.99)
Diluted $ 2.77 $ 0.79 $ (0.99)
Average common shares outstanding:      
Basic 63,040 62,100 60,818
Diluted 63,691 62,685 60,818
Dividends declared per common share: $ 0 $ 0 $ 0.01